Dextrothyroxine therapy for the disordered lipid metabolism of preclinical hypothyroidism.
D000328:Adult; D000368:Aged; D001327:Autoimmune Diseases / Q000150:complications / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications; D003918:Dextrothyroxine / Q000008:administration & dosage / Q000627:therapeutic use*; D048909:Diabetes Complications; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D007037:Hypothyroidism / Q000150:complications* / Q000378:metabolism; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D010919:Placebos; D013966:Thyroiditis / Q000150:complications* / Q000276:immunology / Q000378:metabolism; D014280:Triglycerides / Q000097:blood
D010919:Placebos; D014280:Triglycerides; D003918:Dextrothyroxine; D002784:Cholesterol